(Q38303954)

1 September 2017

Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis (English)

1 reference

1 September 2017

1 reference

5

Pier Paolo Pandolfi

0 references

Suzanne D Turner

object named as

Suzanne D Turner

6

0 references

Brian Huntly

object named as

Brian J Huntly

4

0 references

author name string

Fiona K E Mduff

1

1 reference

1 September 2017

C Elizabeth Hook

2

1 reference

1 September 2017

Reuben M Tooze

3

1 reference

1 September 2017

language of work or name

1 reference

27 June 2011

1 reference

1 September 2017

Laboratory Investigation

1 reference

1 September 2017

91

1 reference

1 September 2017

9

1 reference

1 September 2017

1298-1303

1 reference

Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse

1 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

Role of nucleophosmin in embryonic development and tumorigenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

Mouse models of human chromosomal translocations and approaches to cancer therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

ALK-positive lymphoma: a single disease with a broad spectrum of morphology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

ALK+ lymphoma: clinico-pathological findings and outcome.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

Mice transgenic for NPM-ALK develop non-Hodgkin lymphomas

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166849

10.1038/LABINVEST.2011.96

31 August 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference

1 September 2017

PubMed publication ID

21709672

1 reference